197 related articles for article (PubMed ID: 982623)
1. [Determination of fibrin and fibrinogen split products by their anticoagulant activity].
Belitser VA; Varetskaia TV; Tsynkalovskaia SN; Tsariuk LA; Shevchenko LI
Ukr Biokhim Zh; 1976; 48(4):521-32. PubMed ID: 982623
[TBL] [Abstract][Full Text] [Related]
2. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
Scott WL; Francis CW; Knutson DW; Marder VJ
J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of fibrinuria with fibrinogen split-product E following kidney allotransplantation.
Zühlke V; Hölscher M; Reichel W; Pernice G
Contrib Nephrol; 1975; 1():103-8. PubMed ID: 797519
[TBL] [Abstract][Full Text] [Related]
4. Urine fibrin degradation products in detection and management of acute and chronic renal transplant rejection.
Cattran DC; Hockley M; Fenton SS; Wilson DR
Clin Nephrol; 1977 Jun; 7(6):255-61. PubMed ID: 326454
[TBL] [Abstract][Full Text] [Related]
5. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M
Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
[TBL] [Abstract][Full Text] [Related]
6. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
[TBL] [Abstract][Full Text] [Related]
7. [Determination of fibrin (fibrinogen) degradation products in urine].
Andreenko GV; Podorol'skaia LV
Lab Delo; 1983; (4):35-8. PubMed ID: 6191081
[No Abstract] [Full Text] [Related]
8. [Clinical significance of urinary fibrin-fibrinogen degradation products in renal disease].
Umitsu Y
Nihon Jinzo Gakkai Shi; 1976 Jun; 18(6):371-87. PubMed ID: 988340
[No Abstract] [Full Text] [Related]
9. [Fibrin degradation products in the urine in renal diseases].
Iversen BM; Ofstad J; Thunold S; Willassen Y
Tidsskr Nor Laegeforen; 1976 Jan; 96(2):91-3. PubMed ID: 766292
[No Abstract] [Full Text] [Related]
10. Significance of the quantitative determination of "fibrin degradation products" in renal diseases.
Chin Med J (Engl); 1980 Jul; 93(7):483-6. PubMed ID: 6772396
[No Abstract] [Full Text] [Related]
11. Fibrinogen-fibrin degradation products in renal disorders.
Dube B; Srivastava PK; Padmanabhan R; Dube RK
Indian J Pathol Microbiol; 1979 Oct; 22(4):313-22. PubMed ID: 548482
[No Abstract] [Full Text] [Related]
12. A simple test for early detection of severe renal homograft rejection.
Oppolzer R; Leithner C; Wolf A; Pinggera W; Stummvoll H
Proc Eur Dial Transplant Assoc; 1975; 11():326-32. PubMed ID: 667
[TBL] [Abstract][Full Text] [Related]
13. [Fibrin degradation products in the urine in diabetic nephropathy].
Khristov V; Apostolov P; Stamenova T
Vutr Boles; 1979; 18(4):32-6. PubMed ID: 494630
[TBL] [Abstract][Full Text] [Related]
14. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
Dyr JE; Cajthamlová H; Suttnar J
Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of two new assays for determination of serum fibrinogen/fibrin degradation products.
Sumner K; Feller E; Galanakis DK; Mosesson MW
Ann Clin Lab Sci; 1979; 9(5):362-7. PubMed ID: 533231
[TBL] [Abstract][Full Text] [Related]
16. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of determining urinary fibrin split products in glomerulonephritis, pyelonephritis and graft rejection].
Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
Z Urol Nephrol; 1978 Nov; 71(11):787-97. PubMed ID: 366978
[TBL] [Abstract][Full Text] [Related]
18. Aggristin (ristomycin) precipitation test: a new tool for the detection of fibrin monomer and fibrin degradation products.
Pfliegler G; Vogel G; Boda Z; Zajka G; Rak K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(4):629-35. PubMed ID: 2414192
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine].
Bendel M; Oetliker O; Montandon A; Beck EA
Schweiz Med Wochenschr; 1975 Aug; 105(33):1040-7. PubMed ID: 1099647
[TBL] [Abstract][Full Text] [Related]
20. [Letter: Fibrin metabolites in the urine in kidney diseases].
Arnesen M; Godal HC
Tidsskr Nor Laegeforen; 1976 Feb; 96(6):396. PubMed ID: 1257987
[No Abstract] [Full Text] [Related]
[Next] [New Search]
